Related Experiment Video
Updated: Jan 11, 2026
Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma
Published on: April 20, 2018
Development and Validation of a Predictive Model for Radiotherapy Outcomes in Patients with Head and Neck Tumors
Yun Liu1, Yakun Fang2, Chao Yan3
1Department of Nephrology, Qilu Hospital of Shandong University (Qingdao).
Objective:
To analyze the predictive value of oropharyngeal bacterial infection (the primary adverse radiotherapy outcome investigated in this study) in patients with head and neck tumors (HNTs), identify risk factors, and develop and validate a nomogram prediction model.
Methods:
A total of 260 HNT patients who underwent radiotherapy between January 2021 and January 2023 were enrolled. Univariate and multivariate analyses were performed to screen for factors influencing radiotherapy outcomes. A nomogram prediction model was constructed and validated using the concordance index (C-index), calibration curves, and decision curve analysis (DCA).
Results:
The peripheral blood nCD64 index, peripheral blood CD14 index, neutrophil count, CRP, and serum albumin levels were identified as independent risk factors affecting radiotherapy outcomes (P < 0.05). The constructed nomogram prediction model exhibited excellent discriminative ability (C-index = 0.945, 0.873), good calibration curve agreement, and DCA confirmed its clinical utility.
Conclusion:
The peripheral blood nCD64 index, CD14 index, neutrophil count, CRP, and serum albumin levels influence radiotherapy outcomes. The established nomogram prediction model demonstrates high accuracy and clinical applicability.
Advances In Knowledge:
This study develops and validates a novel nomogram incorporating immune-inflammatory biomarkers (nCD64, CD14, neutrophils, CRP, and albumin) to predict radiotherapy outcomes in head and neck cancer, improving personalized prognostic assessment.
